Financial Performance - Carlyle reported net income attributable to common stockholders of $130 million for Q1 2025, or $0.35 per share on a diluted basis[17]. - Total revenues for Q1 2025 were $973.1 million, a significant increase from $688.4 million in Q1 2024, representing an increase of approximately 41.4%[17]. - Distributable Earnings for Q1 2025 were $455 million, compared to $431 million in Q1 2024, marking an increase of 6%[29]. - The margin on income before provision for income taxes was 17.6% for Q1 2025, slightly up from 17.5% in Q1 2024[17]. - Net income attributable to The Carlyle Group Inc. for 1Q'25 was $130.0 million, compared to $210.9 million in 4Q'24, reflecting a decrease of 38.2%[144]. - The company reported a net investment income (loss) of $6.1 million for 1Q'25, compared to $33.6 million in 4Q'24[144]. Assets Under Management (AUM) - Total assets under management reached $453 billion, up 6% year-over-year, with fee-earning assets under management increasing by 3% to $314 billion[20]. - Total Assets Under Management (AUM) reached $453 billion as of March 31, 2025, up 3% from the previous quarter and 6% year-over-year[45]. - Total AUM in Global Credit reached $199 billion as of March 31, 2025, a 4% increase from the prior quarter and a 7% increase year-over-year[73]. - Total AUM includes Legacy Energy funds, although their impact on overall results has diminished[169]. - Total investments in Carlyle AlpInvest as of March 31, 2025, amounted to $175.6 billion, with a gross IRR of 14% and a net IRR of 13%[112]. Earnings and Dividends - Carlyle declared a quarterly dividend of $0.35 per common share, payable on May 27, 2025[6]. - The estimated distributable earnings per common share for Q1 2025 was $1.14, consistent with the dividend per common share of $0.35[118]. - The company’s dividend policy is set at an annual rate of $1.40 per share, with quarterly payments of $0.35[152]. Investment Activity - Inflows for Q1 2025 amounted to $14.2 billion, contributing to a total of $49.6 billion for the LTM[20]. - Deployment in Q1 2025 was $11.1 billion, with LTM deployment increasing by 45% to $45.9 billion[60]. - Notable Q1 2025 investments included Vantive and deployment in U.S. real estate funds, with realized proceeds from significant transactions totaling $5.0 billion[67]. - The company experienced a 4% increase in Global Credit driven by inflows in insurance solutions and deployment across the platform[55]. Performance Metrics - Fee Related Earnings (FRE) for Q1 2025 were $311 million, with a total of $1.1 billion for the last twelve months (LTM)[20]. - Realized Net Performance Revenues in Q1 2025 were $127 million, down from $142 million in Q1 2024, reflecting a decrease of 11%[29]. - The company reported a significant unrealized performance revenue loss of $564.4 million in Q3 2024, impacting overall performance metrics[123]. - The Corporate Private Equity segment reported a cumulative invested capital of $151.022 billion, with a gross internal rate of return (IRR) of 25% and a net IRR of 17%[102]. Share Repurchase and Capital Management - Carlyle repurchased or withheld 3.3 million shares of common stock in Q1 2025, with $0.7 billion of repurchase capacity remaining under its $1.4 billion repurchase authorization[21]. - The total cost of shares repurchased and retired during the period was $176.5 million, with a remaining repurchase capacity of approximately $0.7 billion as of March 31, 2025[122]. Market and Economic Factors - The company reported foreign exchange gains of $1.795 billion during the quarter, contributing positively to the overall AUM[97]. - The average annual default rate for U.S. CLOs was reported at 0.1%, while European CLOs had a default rate of 0.0% as of Q1 2025[109]. - Market Activity & Other represents realized and unrealized gains (losses) on portfolio investments, affecting overall AUM[174].

Core Points - Centerra Gold Inc. held its 2025 Annual Meeting of Shareholders on May 6, 2025, with 159,054,649 shares represented, accounting for 76.22% of common shares issued and outstanding [1] Group 1: Election of Directors - All nominee directors listed in the management information circular dated March 11, 2025, were elected [2] - Voting results for directors showed high approval rates, with Karen David-Green receiving 99.73% votes for, and Michael S. Parrett receiving 98.14% votes for [3] Group 2: Appointment of Auditors - KPMG LLP was re-appointed as the auditor of the Company, with the Board authorized to fix the auditor's remuneration [4] - The appointment received 95.92% votes for, with 4.08% votes withheld [5] Group 3: Advisory Vote on Executive Compensation - The non-binding resolution approving the Company's approach to executive compensation was approved [6] - The advisory vote on executive compensation received 98.66% votes for, with 1.34% votes against [7] Group 4: Company Overview - Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring, and acquiring gold and copper properties in North America, Türkiye, and other markets worldwide [8]

TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- Centerra Gold Inc. ("Centerra" or the "Company") (TSX: CG) (NYSE: CGAU) announces an updated mineral resource at Kemess, which includes results from the 2024 drilling campaign, and outlines a plan to advance studies on the project. In 2024, Centerra completed over 11,400 meters of core drilling for exploration, geotechnical, and metallurgical testing purposes. Those results have been included in the updated mineral resource as of April 15, 2025. Gold mineral resourc ...

Core Insights - Acentra Health has been awarded a two-year contract worth $27.5 million by the California Department of Health Care Services to provide Level I screenings and Level II evaluations for serious mental illness as part of the PASRR program [1][2] - The company has a long-standing partnership with California Medicaid, having delivered PASRR services since 2015, and is recognized for its efficiency and effectiveness in this area [2][4] - California's PASRR program is the largest in the nation, with Acentra Health conducting approximately 233,000 initial screenings and 18,000 Level II evaluations annually, achieving turnaround times averaging fewer than two calendar days [4][5] Company Overview - Acentra Health specializes in technology and health solutions aimed at improving outcomes for government and commercial healthcare clients [1][7] - The company has over 30 years of experience in evaluating medical necessity for Medicaid beneficiaries and provides a range of PASRR services, including screenings, evaluations, and IT systems [6][7] - Acentra Health has expanded its PASRR portfolio to eight states, recently adding Kansas and Washington, indicating growth and increased market presence [5]

Core Insights - Socially Determined and Acentra Health have partnered to enhance health outcomes through data integration and AI analytics [1][2] - The collaboration aims to improve state healthcare agencies' ability to predict and target interventions, ultimately reducing program costs [1][4] Company Overview - Socially Determined specializes in social risk analytics and solutions, focusing on integrating health and social care [5] - Acentra Health provides technology and health solutions, emphasizing better outcomes for government and commercial healthcare clients [6] Partnership Details - Acentra Health will utilize Socially Determined's advanced social risk data to enhance its analytics capabilities, particularly in Medicaid claims data [2][4] - The partnership aims to transition from reactive care to proactive, targeted interventions by enriching Medicaid data with social risk factors [4][6] Analytical Approach - Acentra Health's "whole person, whole population" analytics model combines community risk factors, individual social risk data, and state-based claims analytics [3][4] - This comprehensive model allows for deeper insights into the factors influencing health outcomes, surpassing traditional claims analysis [3][4] Impact on Healthcare - The integration of social risk data is expected to empower healthcare providers with actionable information for socio-clinically susceptible groups [3][4] - Acentra Health serves healthcare agencies in 46 states, with experience covering over 140 million lives in Medicaid claims data [4][6]

Core Viewpoint - The CEO of Carlyle Group, Harvey Schwartz, indicated that while a recession is a possibility, it is premature to determine its certainty, especially in light of recent tariff announcements by President Trump [1][2]. Market Reactions - Stock markets experienced significant declines following tariff announcements but showed some recovery after Trump paused higher tariff rates on most countries [2]. - The White House announced that Chinese exports could face tariffs as high as 245%, with a general 10% import tariff applied to other countries [2]. Economic Outlook - Schwartz suggested that a recession could be averted if markets establish a "new equilibrium" in the near future, although current uncertainty is causing concern [2][3]. - The uncertainty is impacting decision-making processes, leading CEOs to shift focus from growth strategies to contingency planning [3]. Trade Relations - The ongoing trade tensions between the US and China are seen as a significant risk, with Schwartz emphasizing the need for cooperation to stabilize the global economy [4]. - China's Commerce Ministry has indicated it will retaliate against countries that pursue trade deals with the US that negatively affect Chinese interests [5]. Market Volatility - Schwartz previously advised business leaders to prepare for market volatility due to tariff announcements, suggesting that the current situation requires continued caution [5][6].

Core Viewpoint - Carlyle Secured Lending, Inc. will announce its financial results for the first quarter of 2025 on May 6, 2025, followed by a conference call on May 7, 2025 [1][2]. Company Overview - Carlyle Secured Lending, Inc. is a publicly traded business development company (BDC) that began investing in 2013, focusing on senior secured lending to middle-market companies primarily in the United States [3]. - The company is externally managed by Carlyle Global Credit Investment Management L.L.C., a wholly owned subsidiary of Carlyle [3]. - Carlyle, as a global investment firm, manages $441 billion in assets as of December 31, 2024, and operates across three business segments: Global Private Equity, Global Credit, and Global Investment Solutions [4].

Company Overview - Carlyle Group (CG) shares increased by 11.7% to close at $39.56, following a period of 13.8% loss over the past four weeks, indicating a notable recovery in stock performance [1] - The stock price surge is attributed to a broader market rally driven by President Trump's announcement of a 90-day suspension of reciprocal tariffs for most trading partners, excluding China, which alleviated investor concerns regarding trade tensions [2] Earnings Expectations - Carlyle is expected to report quarterly earnings of $0.97 per share, reflecting a year-over-year decline of 4%, with revenues projected at $987.74 million, down 3.5% from the previous year [3] - The consensus EPS estimate for Carlyle has been revised 1% lower over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Industry Context - Carlyle is part of the Zacks Financial - Investment Management industry, where Affiliated Managers Group (AMG) also operates, having closed the last trading session up 11.5% at $159.83, despite a -10.5% return over the past month [4] - Affiliated Managers' consensus EPS estimate remains unchanged at $5.13, representing a year-over-year change of -4.5%, and it also holds a Zacks Rank of 3 (Hold) [5]

Core Points - Centerra Gold Inc. will release its first quarter 2025 operating and financial results on May 6, 2025, before market opens [1] - A conference call and webcast to discuss the results will take place on the same day at 9:00 a.m. Eastern Time [1] - The annual meeting of shareholders is scheduled for May 6, 2025, at 11:00 a.m. Eastern Time, conducted in a virtual format [3] Company Overview - Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring, and acquiring gold and copper properties in North America, Türkiye, and other global markets [5] - The company operates two mines: the Mount Milligan Mine in British Columbia, Canada, and the Öksüt Mine in Türkiye [5] - Centerra also owns the Kemess Project in British Columbia, the Goldfield Project in Nevada, and operates a Molybdenum Business Unit in the United States and Canada [5]

Welcome to Cash Flow Venue, where dividends do the heavy lifting! Blending my financial chops with the timeless wisdom of value investing (and love for steady income), I've built a rock-solid pillar in my financial foundation through dividend investing. I believe it's one of the most accessible paths to achieving financial freedom, and I'm excited to share my insights with you. I'm a finance professional with deep experience in M&A and business valuation. What does that mean in practice? I've evaluated coun ...